Summit Therapeutics Inc. (SMMT)
NASDAQ: SMMT · Real-Time Price · USD
16.64
-1.21 (-6.78%)
Sep 21, 2026, 2:02 PM EDT - Market open
Summit Therapeutics Market Cap
Summit Therapeutics has a market cap or net worth of $13.27 billion as of September 21, 2026. Its market cap has decreased by -5.40% in one year.
Market Cap
13.27B
Enterprise Value
12.60B
1-Year Change
-5.40%
Ranking
Category
Stock Price
$16.64
ChartMarket Cap Chart
Since March 5, 2015, Summit Therapeutics's market cap has increased from $119.00M to $13.27B, an increase of 11,055.09%. That is a compound annual growth rate of 50.38%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 21, 2026 | 13.27B | 1.95% |
| Dec 31, 2025 | 13.02B | -1.06% |
| Dec 31, 2024 | 13.16B | 619.43% |
| Dec 29, 2023 | 1.83B | 113.79% |
| Dec 30, 2022 | 855.60M | 225.45% |
| Dec 31, 2021 | 262.90M | -32.00% |
| Dec 31, 2020 | 386.60M | 653.61% |
| Dec 31, 2019 | 51.30M | 203.55% |
| Dec 31, 2018 | 16.90M | -87.66% |
| Dec 29, 2017 | 137.00M | 30.60% |
| Dec 30, 2016 | 104.90M | -21.83% |
| Dec 31, 2015 | 134.20M | 12.77% |
| Mar 5, 2015 | 119.00M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Jazz Pharmaceuticals | 15.63B |
| Ascendis Pharma | 15.55B |
| Exelixis | 14.46B |
| BridgeBio Pharma | 13.02B |
| Halozyme Therapeutics | 12.76B |
| BioMarin Pharmaceutical | 12.38B |
| Madrigal Pharmaceuticals | 12.28B |
| Corcept Therapeutics | 11.92B |